Pets
Hot Diggity: PetIQ Could Rally 30% From Here, but There Is Risk
Here's how to play the stock right now.
A Handful of Small Biotechs That Make for Merger Chatter
The names include a veterinary drug concern plus companies with successful drugs on the market.
Not Ready to Bite into Chewy
Trading today would just be a gamble, and at this price, it's a hard bet.
Chewy Aims to Take a Bite Out of the Pet Market on IPO Day
Chewy's initial public offering document has a lot of information for investors to gnaw on, such as its large ongoing losses and its ownership structure.
Zoetis Broke Out to a New High - Hold Longs, Raise Stop Protection
Let's check the charts of this animal health company.
Idexx Labs Could Be Forming a Double Top or Just Pausing in an Uptrend
Shares of the animal health company have not broken out over their highs from last summer, which makes it tough to discern their direction.
This Portfolio of Comeback Kids Continues to Hold Its Own
These 12 companies likely saw their shares hurt by tax-loss selling at the end of 2018, but most are outperforming the market so far this year.
News Surrounds 3 Small Biotechs, With a Merger Claiming One
Two companies in pet pharmaceuticals plan to combine, while two other concerns are worth a look based on developments in their respective spaces.
This Portfolio of Comeback Kids Keeps Delivering the Goods
These 12 companies likely saw their shares hurt by tax-loss selling at the end of 2018, but most are outperforming the market so far this year.
PetIQ Has a Good Story but the Charts Need to Catch Up
Let's check the charts and indicators.